Omnimmune Common Stock from 2010 to 2026
| OMMH Stock | USD 0.0001 0.00 0.00% |
Common Stock | First Reported 2010-12-31 | Previous Quarter 801 | Current Value 760.95 | Quarterly Volatility 637.38334729 |
Check Omnimmune Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Omnimmune Holdings' main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 1.9 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.58, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Omnimmune financial statements analysis is a perfect complement when working with Omnimmune Holdings Valuation or Volatility modules.
Omnimmune | Common Stock | Build AI portfolio with Omnimmune Stock |
Latest Omnimmune Holdings' Common Stock Growth Pattern
Below is the plot of the Common Stock of Omnimmune Holdings over the last few years. It is Omnimmune Holdings' Common Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Omnimmune Holdings' overall financial position and show how it may be relating to other accounts over time.
| Common Stock | 10 Years Trend |
|
Common Stock |
| Timeline |
Omnimmune Common Stock Regression Statistics
| Arithmetic Mean | 1,031 | |
| Geometric Mean | 949.90 | |
| Coefficient Of Variation | 61.84 | |
| Mean Deviation | 290.51 | |
| Median | 890.00 | |
| Standard Deviation | 637.38 | |
| Sample Variance | 406,258 | |
| Range | 2.7K | |
| R-Value | (0.44) | |
| Mean Square Error | 350,360 | |
| R-Squared | 0.19 | |
| Significance | 0.08 | |
| Slope | (55.23) | |
| Total Sum of Squares | 6.5M |
Omnimmune Common Stock History
About Omnimmune Holdings Financial Statements
Investors use fundamental indicators, such as Omnimmune Holdings' Common Stock, to determine how well the company is positioned to perform in the future. Although Omnimmune Holdings' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Common Stock | 801.00 | 760.95 |
Currently Active Assets on Macroaxis
When determining whether Omnimmune Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Omnimmune Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Omnimmune Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Omnimmune Holdings Stock:Check out the analysis of Omnimmune Holdings Correlation against competitors. For more detail on how to invest in Omnimmune Stock please use our How to Invest in Omnimmune Holdings guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omnimmune Holdings. If investors know Omnimmune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omnimmune Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Omnimmune Holdings is measured differently than its book value, which is the value of Omnimmune that is recorded on the company's balance sheet. Investors also form their own opinion of Omnimmune Holdings' value that differs from its market value or its book value, called intrinsic value, which is Omnimmune Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omnimmune Holdings' market value can be influenced by many factors that don't directly affect Omnimmune Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omnimmune Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Omnimmune Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omnimmune Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.